Ascletis Pharma Inc
HKEX:1672
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascletis Pharma Inc
HKEX:1672
|
CN |
|
S
|
SeAH Special Steel Co Ltd
KRX:019440
|
KR |
|
Cross-Harbour Holdings Ltd
HKEX:32
|
HK |
|
E
|
Eureka Acquisition Corp
NASDAQ:EURK
|
CN |
|
G
|
General Electric Co
SGO:GE
|
US |
|
A
|
Alfi Inc
OTC:ALFIQ
|
US |
|
T
|
Tiger Brands Ltd
JSE:TBS
|
ZA |
|
R
|
RFM Corp
XPHS:RFM
|
PH |
|
P
|
Protec Co Ltd
KOSDAQ:053610
|
KR |
|
Tremor International Ltd
LSE:TRMR
|
IL |
|
Voith Paper Fabrics India Ltd
BSE:522122
|
IN |
|
D
|
Digitalist Group Oyj
OMXH:DIGIGR
|
FI |
|
R Systems International Ltd
NSE:RSYSTEMS
|
IN |
|
B
|
Baguio Green Group Ltd
HKEX:1397
|
HK |
|
Zurich Insurance Group AG
LSE:0QP2
|
CH |
|
S
|
Sekisui Jushi Corp
TSE:4212
|
JP |
|
Hello Group Inc
NASDAQ:MOMO
|
CN |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
China Mobile Ltd
SSE:600941
|
CN |
|
Northland Power Inc
TSX:NPI
|
CA |
|
Aspen Group Ltd
ASX:APZ
|
AU |
|
Everest Kanto Cylinder Ltd
NSE:EKC
|
IN |
|
J
|
Jiangsu Sidike New Materials Science & Technology Co Ltd
SZSE:300806
|
CN |
Ascletis Pharma Inc
Ascletis Pharma, Inc. operates as biotechnology firm to test the waters. The company is headquartered in Hangzhou, Zhejiang and currently employs 266 full-time employees. The company went IPO on 2018-08-01. The firm is focused on three therapeutic areas, including anti-viral, cancer and fatty liver disease. The Company’s main products include drugs against hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Ascletis Pharma, Inc. operates as biotechnology firm to test the waters. The company is headquartered in Hangzhou, Zhejiang and currently employs 266 full-time employees. The company went IPO on 2018-08-01. The firm is focused on three therapeutic areas, including anti-viral, cancer and fatty liver disease. The Company’s main products include drugs against hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
